X-Pure® gelatin outperformed standard research grade gelatins and other coating materials in 2D cell culturing
Rousselot B.V. and Zerion Pharma ApS announce today that they have strengthened their partnership through an extension of an exclusive license agreement entered into in 2019.
Rousselot® Biomedical lanza Quali-Pure™, una gama de gelatinas con pureza controlada, compatible con el pleno cumplimiento de la nueva normativa de la UE sobre dispositivos médicos y la norma ISO…
Rousselot and Antleron announce collaboration. Rousselot offers customizable, ultra-pure gelatins and collagens to the biomedical market while Antleron is an ecosystem R&D company providing…
We are proud to co-present a lunch symposium with Dr Jeroen Leijten, University of Twente, Enschede, Netherlands and our scientific expert Dr Jeff Daelman, in which the complexities and potential of…
Rousselot® is thrilled to be attending this year’s BIO Digital event June 10-11 & 14-18, 2021 Our expert, scientifically savvy business development team is looking forward to ‘meeting’ with industry…